Forecast for Vaccine Stocks After Coronavirus Pandemic Passes
Stephen Gardner, director at ETF Managers Group, explains why investors shouldn't be rushing to sell vaccine stocks like Moderna or BioNTech even as the spread of COVID-19 slows down.
More Videos
How AI Is Quietly Transforming the Way America's Biggest Restaurants Operate
Lavu CEO Saleem Khatri joins to explain how AI-powered POS systems are changing how major franchises like KFC take orders, cut costs, and serve customers faster
How BillionToOne's Unity Testing System Is Redefining Prenatal Genetic Screening
BillionToOne's Jen Hoskovec breaks down the Unity test, the latest in prenatal genetic screening, and what it means for those born with genetic conditions.
Ingram Micro CFO on Navigating Market Uncertainty and Where AI Is Actually Delivering Results
Mike Zilis, CFO of Ingram Micro, breaks down capital strategy, current market pressures, and how to tell meaningful AI impact from the hype.
Your Pocket-Sized Bodyguard Is Here: Meet Bond!
Bond CEO Doron Kempel on how his company is putting professional-grade personal security in the hands of everyday Americans.
Thinking Crypto's Tony Edward on Bitcoin's Biggest Milestone Yet
20 million bitcoins are now in circulation. Author and podcast host Tony Edward joins us to unpack the milestone and the state of crypto today.
From Coffee Shops to Everywhere: SoundHound's Keyvan Mohajer on Voice AI's Expanding Reach
SoundHound Co-Founder and CEO Keyvan Mohajer introduces the company's Voice AI technology and discusses a recent partnership with Peet's Coffee.
